Candriam S.c.a.’s Johnson & Johnson Position
Does Candriam S.c.a. own Johnson & Johnson (JNJ)? Yes — 749.6K shares worth $155M (+0.77% of its 13F portfolio) as of Q1 2026, down from 750.5K shares the prior filed quarter.
Position Value
$155M
Q1 2026
Shares
749.6K
% of Portfolio
+0.77%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 749.6K | $155M | +0.77% |
| Q4 2025 | 750.5K | $155M | +0.77% |
| Q3 2025 | 636.0K | $118M | +0.62% |
| Q2 2025 | 295.7K | $45M | +0.26% |
| Q1 2025 | 299.1K | $50M | +0.31% |
| Q4 2024 | 277.1K | $40M | +0.23% |
| Q3 2024 | 265.2K | $43M | +0.25% |
| Q2 2024 | 280.2K | $41M | +0.25% |
| Q1 2024 | 273.5K | $43M | +0.28% |
| Q4 2023 | 307.2K | $48M | +0.33% |
| Q3 2023 | 486.9K | $76M | +0.54% |
| Q2 2023 | 819.6K | $136M | +0.98% |
| Q1 2023 | 863.5K | $123M | +0.85% |
| Q4 2022 | 691.1K | $122M | +0.82% |
| Q3 2022 | 495.8K | $81M | +0.57% |
| Q2 2022 | 641.8K | $114M | +0.94% |
| Q1 2022 | 871.7K | $154M | +1.05% |
| Q4 2021 | 875.3K | $150M | +0.96% |
| Q3 2021 | 982.4K | $159M | +1.08% |
| Q2 2021 | 645.2K | $106M | +0.73% |
| Q1 2021 | 603.9K | $91M | +0.76% |
| Q4 2020 | 604.0K | $95M | +0.75% |
| Q3 2020 | 416.2K | $62M | +0.58% |
| Q2 2020 | 410.4K | $58M | +0.61% |
| Q1 2020 | 395.6K | $56M | +0.63% |
| Q4 2019 | 395.6K | $58M | +0.62% |
| Q3 2019 | 416.5K | $58,000 | +0.73% |
| Q2 2019 | 412.5K | $62M | +0.78% |
| Q1 2019 | 398.6K | $61M | +0.78% |
| Q4 2018 | 377.5K | $49M | +0.75% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Candriam S.c.a.’s full portfolio or all institutional holders of JNJ.